Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.
www.marketwatch.com
#Becton #Dickinson #spinoff #deal #stock #falling
Related Posts

Paramount revives ‘Rush Hour 4’ after Trump request
Actors Chris Tucker and Jackie Chan arrive to the premiere of “Rush Hour 3” at Mann’s Chinese Theater on July…

CrowdStrike (CRWD) Expands AWS Partnership to Power AI Security Solutions
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is one of the AI Stocks Investors Are Watching Closely. On July 16, Crowdstrike announced an expanded…

SpaceX snags Street-high $300 price target at MS as firm enters Nasdaq 100
Morgan Stanley initiated coverage of SpaceX (SPCX) on Tuesday with an Overweight rating and a $300 price target. It’s the…

